Tag: capital

Hepsor AS, registry code 12099216 (the Company) Supervisory Board adopted a decision on 8 July 2025 to increase the share capital of the company by EUR 57,821. The increase of the share capital is linked to the acquisition of a 20% stake in Hepsor Latvia OÜ (registry code 16193797) from Hugomon OÜ (registry code 14221704), approved by a shareholders' resolution of 12 June 2025, for which the company will pay in part by issuing shares in the company to Hugomon OÜ.

Fiscal Year 2025 Earnings

LOS ANGELES, July 08, 2025 (GLOBE NEWSWIRE) -- Capital World Investors (“CWI”) announces that on July 8, 2025 it acquired an aggregate of 338,554 common shares (the “Purchased Shares”) of MEG Energy Corp. (“MEG”) through the facilities of the Toronto Stock Exchange. Immediately following the acquisition of the Purchased Shares, CWI had control or direction over an aggregate of 22,281,631 common shares of MEG representing 8.75% of the 254,378,035 MEG common shares then outstanding.

NEW YORK and NEW ORLEANS, July 08, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 22, 2025 to file lead plaintiff applications in a securities class action lawsuit against Red Cat Holdings, Inc. (NasdaqCM: RCAT), if they purchased the Company’s securities between March 18, 2022 and January 15, 2025, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of New Jersey.

WALTHAM, Mass. and BOULDER, Colo., July 08, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the pricing of its previously announced underwritten public offering of 22,222,223 shares of its common stock, offered at a public offering price of $9.00 per share. The aggregate gross proceeds to Cogent from this offering are expected to be approximately $200 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Cogent has granted the underwriters a 30-day option to purchase up to an additional 3,333,333 shares of its common stock on the same terms and conditions. All of the securities in the offering are being sold by Cogent. The offering is expected to close on or about July 10, 2025, subject to the satisfaction of customary closing conditions.